Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ainoleena Turku

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Methods in Enzymology|August 29, 2018
Defining Dynamics of Membrane-Bound Pyrophosphatases by Experimental and Computational Single-Molecule FRETSteven P D Harborne, Jannik Strauss, Ainoleena Turku, et al.
Journal of Visualized Experiments : Jove|December 10, 2019
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase InhibitorsKeni Vidilaseris, Niklas G Johansson, Ainoleena Turku, et al.
Chemmedchem|March 21, 2019
Structure-Activity Relationships of 1-Benzoylazulenes at the OX<sub>1</sub> and OX<sub>2</sub> Orexin ReceptorsAinoleena Turku, Teppo O Leino, Lasse Karhu, et al.
European Journal of Pharmacology|September 9, 2018
Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26Maiju K Rinne, Teppo O Leino, Ainoleena Turku, et al.
Structural Dynamics (Melville, N.Y.)|March 28, 2017
Insights into the mechanism of membrane pyrophosphatases by combining experiment and computer simulationNita R Shah, Craig Wilkinson, Steven P D Harborne, et al.
Nature Communications|January 23, 2020
Structural insight into small molecule action on FrizzledsPaweł Kozielewicz, Ainoleena Turku, Carl-Fredrik Bowin, et al.
Bioorganic & Medicinal Chemistry|May 20, 2023
Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonistsTeppo O Leino, Ainoleena Turku, Lauri Urvas, et al.
Plos One|April 12, 2018
Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase CRiccardo Provenzani, Ilari Tarvainen, Giulia Brandoli, et al.
Science Advances|September 13, 2021
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicineYitian Zhou, Gabriel Herras Arribas, Ainoleena Turku, et al.
Science Advances|May 28, 2019
Asymmetry in catalysis by <i>Thermotoga maritima</i> membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitorKeni Vidilaseris, Alexandros Kiriazis, Ainoleena Turku, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Methods in Enzymology|August 29, 2018
Defining Dynamics of Membrane-Bound Pyrophosphatases by Experimental and Computational Single-Molecule FRETSteven P D Harborne, Jannik Strauss, Ainoleena Turku, et al.
Journal of Visualized Experiments : Jove|December 10, 2019
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase InhibitorsKeni Vidilaseris, Niklas G Johansson, Ainoleena Turku, et al.
Chemmedchem|March 21, 2019
Structure-Activity Relationships of 1-Benzoylazulenes at the OX<sub>1</sub> and OX<sub>2</sub> Orexin ReceptorsAinoleena Turku, Teppo O Leino, Lasse Karhu, et al.
European Journal of Pharmacology|September 9, 2018
Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26Maiju K Rinne, Teppo O Leino, Ainoleena Turku, et al.
Structural Dynamics (Melville, N.Y.)|March 28, 2017
Insights into the mechanism of membrane pyrophosphatases by combining experiment and computer simulationNita R Shah, Craig Wilkinson, Steven P D Harborne, et al.
Nature Communications|January 23, 2020
Structural insight into small molecule action on FrizzledsPaweł Kozielewicz, Ainoleena Turku, Carl-Fredrik Bowin, et al.
Bioorganic & Medicinal Chemistry|May 20, 2023
Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonistsTeppo O Leino, Ainoleena Turku, Lauri Urvas, et al.
Plos One|April 12, 2018
Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase CRiccardo Provenzani, Ilari Tarvainen, Giulia Brandoli, et al.
Science Advances|September 13, 2021
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicineYitian Zhou, Gabriel Herras Arribas, Ainoleena Turku, et al.
Science Advances|May 28, 2019
Asymmetry in catalysis by <i>Thermotoga maritima</i> membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitorKeni Vidilaseris, Alexandros Kiriazis, Ainoleena Turku, et al.
Pageof 3